日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

FOXM1-specific TCR-engineered T cells target non-small cell lung cancer

针对FOXM1的TCR工程化T细胞靶向非小细胞肺癌

Bontekoe, Emily; Zhang, Minying; Jiang, Peixin; Montoya, Amanda; Shulga, Yulia; Slone, Jared K; Paul, Emily; Polera, Christopher; Forward, Sarah; Nassif Rausseo, Barbara; Assita, Emane Rose; Xing, Changsheng; Molkentine, David P; Morris, Benjamin B; Polic, Isabella; Roszik, Janos; Salgado, Ricardo; Vaishnavi, Aria; Deniger, Drew; Tran, Hai T; Gibbons, Don L; Vaporciyan, Ara; Gillison, Maura L; Wistuba, Ignacio I; Kavraki, Lydia E; Zhang, Jianjun; Lizee, Gregory; Yee, Cassian; Hwu, Patrick; Kwok, Sheldon; Jaeger, Alex M; Heymach, John V; Reuben, Alexandre

Survival Assessment by Central Review vs. Local Investigator in Metastatic Melanoma: A Systematic Review and Meta-Analysis

转移性黑色素瘤患者生存评估:中心审查与地方研究者评估的比较:系统评价和荟萃分析

Eljilany, Islam; Jafari, Eissa; Alhumaid, Abdullah; Eroglu, Zeynep; Brohl, Andrew S; Karapetyan, Lilit; Markowitz, Joseph; Khushalani, Nikhil I; Hwu, Patrick; Tarhini, Ahmad A

CAR Signaling Informs Mechanisms to EnhanceMetabolism and Function in γδ T Cells

CAR信号传导调控γδ T细胞代谢和功能的增强机制

Perez, Xiomar Bustos; Tordesillas, Leticia; Martinez-Planes, Elena; Fontela, Miguel G; Rossetti, Renata Marques; Izumi, Victoria; Fang, Bin; Koomen, John; Welsh, Eric; Hwu, Patrick; Abate-Daga, Daniel

Advancing human leukocyte antigen-based cancer immunotherapy: from personalized to broad-spectrum strategies for genetically heterogeneous populations

推进基于人类白细胞抗原的癌症免疫疗法:从个性化策略到针对遗传异质性人群的广谱策略

Oseni, Saheed Oluwasina; Wang, Yunfei; Hwu, Patrick

Multicellular immune ecotypes within solid tumors predict real-world therapeutic benefits with immune checkpoint inhibitors

实体瘤内的多细胞免疫生态型可预测免疫检查点抑制剂在现实世界中的治疗效果

Wang, Xuefeng; Li, Tingyi; Eljilany, Islam; Soupir, Alex; Radmacher, Michael; Agius, Phaedra; Sukrithan, Vineeth; Ratan, Aakrosh; McCarter, Martin; Salhia, Bodour; Colman, Howard; Naqash, Abdul R; Puzanov, Igor; Arnold, Susanne; Marin-Acevedo, Julian A; Ganesan, Shridar; Churchman, Michelle; Hwu, Patrick; Rodriguez, Paulo C; Dalton, William S; Weiner, George J; Tarhini, Ahmad A

Structure-guided engineering of CD112 receptor variants for optimized immunotherapy

通过结构导向工程改造CD112受体变体以优化免疫疗法

Singh, Srishti; Julia, Estefania; Kalita, Parismita; Mason, Charlotte; Ming, Qianqian; Lee-Sam, Ansar; Gordon, Sumai; Buitrago, Maria Emilia; Leung, Daisy W; Hwu, Patrick; Luca, Vincent C

SITC perspective: leveraging patient enrichment biomarkers to accelerate early phase IO drug development

SITC观点:利用患者富集生物标志物加速早期免疫肿瘤药物研发

Emens, Leisha A; Moussion, Christine; Hwu, Patrick; Gulley, James L; Ohashi, Pamela S; Bifulco, Carlo B; Feltquate, David

Facts and Hopes: Toward the Next Quantum Leap in Melanoma

事实与希望:迈向黑色素瘤的下一个量子飞跃

Flaherty, Keith T; Aplin, Andrew E; Davies, Michael A; Hacohen, Nir; Herlyn, Meenhard; Hoon, Dave; Hwu, Patrick; Lotem, Michal; Mulé, James; Wargo, Jennifer A; Fisher, David E

Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma

整合循环和肿瘤互补生物标志物的免疫特征可最大限度地提高高危黑色素瘤辅助免疫治疗获益的预测能力

Tarhini, Ahmad A; Obermayer, Alyssa; Lee, Sandra J; LaFramboise, William A; Hodi, F Stephen; Karunamurthy, Arivarasan D; Eljilany, Islam; Chen, Dung-Tsa; Hwu, Patrick; El Naqa, Issam M; Streicher, Howard; Sondak, Vernon K; Storkus, Walter J; Butterfield, Lisa H; Shaw, Timothy I; Kirkwood, John M

Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanoma

转移性黑色素瘤患者的淋巴细胞清除、肿瘤浸润淋巴细胞、高剂量与低剂量IL-2联合帕博利珠单抗治疗

Hasanov, Merve; Kiany, Simin; Forget, Marie-Andrée; Bassett, Roland; Davies, Michael A; Diab, Adi; Gershenwald, Jeffrey E; Glitza, Isabella C; Lee, Jeffrey E; Lucci, Anthony; McQuade, Jennifer L; Patel, Sapna P; Ross, Merrick I; Tawbi, Hussein A; Wargo, Jennifer A; Wong, Michael K; Bernatchez, Chantale; Hwu, Patrick; Haymaker, Cara; Amaria, Rodabe N